Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -641 | 128 | 381 | 750 | 482 |
| Depreciation Amortization | 182 | 606 | 433 | 269 | 118 |
| Accounts receivable | 480 | -531 | -55 | -786 | 148 |
| Accounts payable and accrued liabilities | -82 | 653 | -46 | -141 | -43 |
| Other Working Capital | -2 | 18 | -42 | -1,006 | -498 |
| Other Operating Activity | -216 | 988 | 939 | 1,314 | 129 |
| Operating Cash Flow | $-279 | $1,862 | $1,610 | $400 | $336 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -749 | -834 | -693 | -486 | -211 |
| Investing Cash Flow | $-749 | $-834 | $-693 | $-486 | $-211 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7 | -262 | N/A | -40 | N/A |
| Common Stock Issued | N/A | 1,465 | 1,440 | 1,076 | 42 |
| Other Financing Activity | 0 | 0 | -53 | 0 | -7 |
| Financing Cash Flow | $-7 | $1,203 | $1,387 | $1,036 | $35 |
| Beginning Cash Position | 3,237 | 1,006 | 1,006 | 1,006 | 1,006 |
| End Cash Position | 2,202 | 3,237 | 3,310 | 1,956 | 1,166 |
| Net Cash Flow | $-1,035 | $2,231 | $2,304 | $950 | $160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -279 | 1,862 | 1,610 | 400 | 336 |
| Capital Expenditure | -749 | -834 | -693 | -486 | -211 |
| Free Cash Flow | -1,028 | 1,028 | 917 | -86 | 125 |